The mechanism of dietary cholesterol effects on lipids metabolism in rats by Wang, Yu-Ming et al.
RESEARCH Open Access
The mechanism of dietary cholesterol effects on
lipids metabolism in rats
Yu-Ming Wang
1†, Bei Zhang
1†, Yong Xue
1, Zhao-Jie Li
1, Jing-Feng Wang
1, Chang-Hu Xue
1*, Teruyoshi Yanagita
2
Abstract
Background: Cholesterol administration has been reported to influence hepatic lipid metabolism in rats. In the
present study, the effect of dietary cholesterol on hepatic activity and mRNA expression of the enzymes involved
in lipid metabolism were investigated. Fourteen male Wistar rats were randomly divided into 2 groups and fed 1%
cholesterol or cholesterol free AIN76 diets for 4 weeks.
Results: The serum triglyceride and high density lipoprotein cholesterol levels were significantly decreased but the
total cholesterol and non high density lipoprotein cholesterol levels were significantly increased in the cholesterol-
fed rats compared with the control rats. And the concentrations of the hepatic total cholesterol and triglyceride
increased about 4-fold and 20-fold separately by dietary cholesterol. The activities of hepatic malic enzyme,
glucose-6-phosphate dehydrogenase, fatty acid synthase, phosphatidate phophatase and carnitine palmitoyl
transferase were depressed by the cholesterol feeding (40%, 70%, 50%, 15% and 25% respectively). The results of
mRNA expression showed that fatty acid synthase, carnitine palmitoyl transferase 1, carnitine palmitoyl transferase
2, and HMG-CoA reductase were down-regulated (35%, 30%, 50% and 25% respectively) and acyl-CoA: cholesterol
acyltransferase and cholesterol 7a-hydroxylase were up regulated (1.6 and 6.5 folds) in liver by the cholesterol
administration.
Conclusions: The dietary cholesterol increased the triglyceride accumulation in liver, but did not stimulate the
activity and the gene expression of hepatic enzymes related to triglyceride and fatty acid biosynthesis.
Background
The high dietary cholesterol was concerned with the
increasing concentrations of serum and hepatic total
cholesterol(TC), especially the level of very low density
lipoprotein (VLDL) and low density lipoprotein (LDL)
in serum, which is considered to be a primary risk factor
of cardiovascular disease. Hypercholesterolemia rat
model is represented for cardiovascular and cerebrovas-
cular disease research, which can be established by feed-
ing with 0.5%-1.0% cholesterol-supplement diet for
several weeks. Dietary 0.5%-1.0% cholesterol can
increase serum VLDL and LDL levels dramatically in
rats. In this case, dietary cholesterol remarkably dis-
turbed triglyceride (TG) metabolism, the hepatic TG
content increased in folds until hepatic steatosis forms.
Thereby, it has been developed as a non-alcoholic fatty
liver disease (NAFLD) model induced by diet in some
previous studies. However, the mechanism of the rat
hypercholesterolemia and NAFLD by high dietary cho-
lesterol has not been systematically investigated.
Numerous studies have been done to seek the effect of
dietary cholesterol on hepatic lipid homeostasis. In early
1990s, Thomas et al. [1,2] has investigated the effect of
cholesterol on the accumulation of liver lipids through
the radioisotope
14C-fatty acid and proposed that the
hepatic TG accumulation was developed by the
enhancement of hepatic TG synthesis and the reduction
of fatty acid beta-oxidation. Liu et al.[ 3 ]h a ss u g g e s t e d
the roles of increased lipogenesis, decreased oxidation of
fatty acids and decreased secretion of VLDL as causes
for the accumulation of TG in the liver in the choles-
terol-fed rats. Xu et al.[ 4 ]h a sa l s or e p o r t e dt h a tt h e
impaired hepatic lipid homeostasis because of lipid
accumulation attributed to the increasing activity of the
enzymes involved in fatty acid biosynthesis in the rats
by the dietary cholesterol. But in our study, we found
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capacity did not increase by the dietary cholesterol.
Besides, some researchers [5] thought the cholesterol
synthesis was abolished in the high-cholesterol-fed rats,
while we suggested the cholesterol administration
affected not only the cholesterol catabolism but also the
cholesterol biosynthesis. So the mechanism of dietary
cholesterol on lipid metabolism is still unclear.
As we know, VLDL is assembled in liver and secreted to
serum, and high hepatic TG level induces high serum TG
concentration. That is because VLDL is mainly composed
of TG. But our previous research found that cholesterol
feeding significantly increased the hepatic TG level, but
reduced the serum TG content obviously as compared
with the controls. So we came up with our hypothesis
based on the above that incorporation of cholesterol ester
(CE) into the VLDL particles takes priority amid VLDL
assembly in comparison with TG in cholesterol-fed rats.
In order to test and verify our hypothesis, we focused on
t h ee f f e c to fd i e t a r yc h o l e s t e r o lo nt h ea c t i v i t yo ft h e
enzymes involved in fatty acid and cholesterol metabolism
in rat liver. The enzymes correlated to TG homeostasis
were determined as follows: fatty acid synthase(FAS),
malic enzyme(ME) and glucose-6-phosphate dehydrogen-
ase (G6PDH), and carnitine palmitoyl transferase (CPT).
To gain intensive insight into fatty acid metabolism, the
following genes expressing the following proteins were
measured: CPT1 and CPT2. With regard to the choles-
terol homeostasis, the activity of phosphatidate phophatase
(PAP) and the mRNA expression of HMG-CoA reductase,
acyl-CoA: cholesterol acyltransferase (ACAT) and choles-
terol 7a-hydroxylase1 (CYP7A1) were measured.
Materials and methods
Animals and diets
Fourteen male Wistar rats, 5 wk old, were purchased
from Qingdao animal center (Qingdao, China). The rats
were housed in metal cages in a temperature-controlled
room under a 12-h light/dark cycle. After a 1 wk adap-
tation period on powder chow diet, the rats were ran-
domly assigned to 2 groups (n = 7) according to the
fasted body weights and pair-fed (providing the rats
each day with the amount of food eaten by matched
freely fed animals) with 1% cholesterol or cholesterol
free AIN76 diet (Table 1). After 4 wk feeding, the final
fasted body weight was weighed, and all rats were killed
by aortic exsanguination under diethyl ether anesthesia.
Liver and white adipose tissues(W.A.T.s, perirenal, epi-
didymal, omental and subcutaneous fat) were excised
immediately, and serum was separated from the blood
for analysis. All aspects of the experiment were con-
ducted according to the guidelines provided by the ethi-
cal committee of experimental animal care at Ocean
University of China (OUC, China).
Serum and liver lipids
Serum was separated by centrifuging the blood at
7500*g for 15 min. Triglyceride (TG, Cat.F001), total
cholesterol (TC, Cat.F002), high density lipoprotein-cho-
lesterol (HDL-c, Cat.F003), non-esterified fatty acid
(NEFA, Cat.A042), and glucose(Cat.F006) were mea-
sured using enzymatic reagent kits from Biosino (Beij-
ing, China). Phospholipid (PL, Cat. 467-32101) was
measured using assay kit from Wako Pure Chemicals
(Tokyo, Japan). Liver lipids were extracted and purified
according to the method of Folch et al. [6]. The concen-
trations of TG, TC and PL were measured according to
the methods of Fletcher [7], Sperry [8] and Bartlett [9].
Assays of enzyme activity
A piece of liver was homogenized in a 0.25 mol/L
sucrose solution that contained 1 mol/L of ethylene-dia-
minetetraacetic diaminetetraacetic acid (EDTA) in a 10
mol/L Tris-HCl buffer (pH 7.4). After precipitating the
nuclei fraction, the supernatant was centrifuged at
10,000*g for 10 min at 4°C to obtain mitochondria. The
resulting supernatant was recentrifuged at 125,000*g for
60 min to precipitate microsomes, and the remaining
supernatant was used as the cytosol fraction. The pro-
tein concentration was determined according to the
method of Lowry et al., with bovine serum albumin
used as the standard. The enzyme activities of ME,
G6PDH and FAS[10-12] in the liver cytosol fraction,
mitochondrial CPT[11] and microsomal PAP [13] were
determined as described.
Determination of mRNA levels from liver
Total cellular RNA was isolated from liver samples
using the Trizol reagent (Invitrogen, Caelsbad, CA),
according to the manufacturer’s recommended proce-
dures. Assays-on-Demand, Gene Expression Products
[Mm00662319_m1 for FAS, Mm00486279_m1 for
ACAT, and Hs99999901_s1 for 18SRNA, Applied Bio-
systems, Tokyo, Japan) and TaqMan MGB Gene
Table 1 Compositions of diets for different rat groups
Control Cholesterol
Casein(g) 20 20
Starch(g) 15 15
Vitamin(AIN-76)(g) 1 1
Mineral(AIN-76)(g) 3.5 3.5
Choline bitartrate(g) 0.2 0.2
Cellulose(g) 5 5
DL-Methionine(g) 0.3 0.3
Corn oil(g) 10 10
Sucrose(g) 45 43.75
Cholesterol(g) 0 1
Bile salt (pig)(g) 0 0.25
Total(g) 100 100
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mer,5’-AGTGATTGTGTCAGTATTATTGTGGAAG-3’;
reverse primer,5’-GGTA CTGGCTGAAAAGTCACAA-
GAG-3’; and TaqMan MGB probe, 5’-FAM-
TTGCTGTTGTATGTAAAG\T-MGB-3’)w e r eu s e df o r
the quantitative real-time reverse transcribed polymerase
chain reaction(RT-PCR) analysis of FAS, ACAT,
18SRNA, and HMG-CoA reductase expression in the
liver. The amplification was performed with a real-time
PCR system (ABI Prism 7000 Sequence Detection Sys-
tem; Applied Biosystems). Results were expressed as a
relative value after normalization to18S RNA[14].
Statistical analysis
All values are expressed as mean ± S.E.M. Means of the
two groups were compared by Student’stt e s tfor each
experiment. Differences were considered to be signifi-
cant at P < 0.05.
Results
Effects of cholesterol on the growth parameters
Table 2 summarized the growth parameters of Wistar
rats after 4 weeks of feeding on the different diets.
Though there was no significant difference in body
weight gain, food intake or total white adipose tissues
between the two groups, the cholesterol diet drastically
increased the liver weight (P < 0.001).
Effects of cholesterol on the concentrations of serum
lipids and glucose
As shown in Table 3, the concentrations of the serum
TC and non-HDL-c were significantly higher (P < 0.001,
P < 0.001) but the HDL-c and TG levels were remark-
ably lower (P < 0.001, P <0 . 0 0 1 )in the cholesterol-fed
rats compared with the control rats. These results indi-
cated that the cholesterol administration developed lipid
metabolic dysfunction, and promoted hyperlipidemia.
Additionally, the cholesterol treatment did not affect the
serum PL, NEFA and glucose levels. The concentration
of serum phospholipids, the main contents of the sur-
face of lipoprotein, did not significantly change by diet-
ary cholesterol, but the LDL-c level was dramatically
higher (P < 0.001) in the cholesterol group than
controls. The result may illustrate that the serum lipo-
protein of the cholesterol-fed rats mainly consist of LDL
of large particle size, which was abundant in cholesterol,
or dietary cholesterol suppressed the TG level and
increased the concentration of CE in the serum
lipoprotein.
Effect of cholesterol on the concentrations of hepatic
lipid
Table 4 showed the hepatic lipid levels of Wistar rats
after 4 weeks of feeding of the diets. Cholesterol feeding
disturbed hepatic lipid metabolism in rats. The concen-
trations hepatic TC and TG remarkably increased by
19.2 folds (P < 0.001) and 2.52 folds (P <0 . 0 0 1 )r e s p e c -
tively, while the PL level decreased significantly (15.4%,
P < 0.001) in cholesterol group as compared with the
controls.
Effect of cholesterol on enzyme activity involved in
hepatic lipid metabolism
Table 5 demonstrated that cholesterol administration
significantly inhibited the activities of the enzymes
related to lipogenesis such as FAS, ME and G6PDH,
and the activity of PAP, a rate-limiting enzyme in TG
synthesis by 50% (P < 0.001), 40% (P <0 . 0 0 1 ) ,7 0 %( P <
0.001) and 15% (P < 0.001 )respectively as compared
with the control diet. Moreover, the hepatic mitochon-
drial beta-oxidation, whose rate-limiting enzyme is CPT
was remarkably suppressed by 25% (P < 0.001 ) by Table 2 Effects of cholesterol on the growth parameters
in Wistar rats
1
Control Cholesterol
Initial B.W. (g) 197 ± 2 197 ± 2
Final B.W. (g) 305 ± 4 310 ± 6
Food intake (g/d) 24.8 ± 0.5 24.6 ± 0.4
Total W.A.T. (g/100 g B.W.) 5.62 ± 0.38 4.99 ± 0.34
Liver weight (g) 12.1 ± 0.7 17.0 ± 0.9*
1Data are presented as mean ± S.E.M. n = 7 rats per group.
B.W., body weight; W.A.T., white adipose tissue.
*P < 0.001, Compared to control group.
Table 3 Effects of cholesterol on concentrations of serum
lipids and glucose in Wistar rats
1
Control Cholesterol
TG (mmol/L) 1.27 ± 0.16 0.67 ± 0.11*
TC (mmol/L) 2.29 ± 0.18 4.92 ± 0.91*
HDL-c (mmol/L) 1.57 ± 0.09 0.78 ± 0.07*
(VLDL+LDL)-c (mmol/L) 0.72 ± 0.17 4.14 ± 0.96*
PL(mmol/L) 2.08 ± 0.13 1.91 ± 0.05
NEFA (mmol/L) 0.453 ± 0.037 0.420 ± 0.039
Glucose (mmol/L) 9.78 ± 0.61 9.33 ± 0.44
1Data are presented as mean ± S.E.M. n = 7 rats per group.
TG, triglyceride; TC, total cholesterol; HDL-c, high density lipoprotein
cholesterol; VLDL-c, very low density lipoprotein cholesterol; PL, phospholipid;
NEFA, non-esterified fatty acid.
*P < 0.001, compared to control group.
Table 4 Effects of cholesterol on concentrations of hepa-
tic lipid in Wistar rats
1
Control Cholesterol
TG (mmol/100 g Liver) 4.23 ± 0.80 10.6 ± 1.02*
TC (mmol/100 g Liver) 0.93 ± 0.05 17.93 ± 0.57*
PL (mmol/100 g Liver) 4.61 ± 0.12 3.90 ± 0.12*
1Data are presented as mean ± S.E.M. n = 7 rats per group.
TG, triglyceride; TC, total cholesterol; PL, phospholipid.
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reduced the activity of hepatic enzymes involved in fatty
acid biosynthesis and beta-oxidation and TG synthesis.
Effect of cholesterol on mRNA expression of hepatic fatty
acid metabolism enzymes
Figure 1 showed hepatic mRNA levels of Wistar rats
after 4 weeks of feeding of the diets. Consistent with the
activity of the enzymes correlated to lipogenesis capa-
city, mRNA expression of FAS, G6PDH and ME
decreased (35%,59% and 44%) (P < 0.01)dramatically by
dietary cholesterol (Figure 1A). As shown in Figure 1B,
the cholesterol administration significantly depressed the
mRNA abundances of CPT1 (P < 0.01) and CPT2 (P <
0.01), which corresponded with the change of the activ-
ity involved in fatty acid beta-oxidation.
Effect of cholesterol on mRNA expression of hepatic
cholesterol metabolism enzymes
Figure 2 showed the hepatic mRNA abundances of Wis-
tar rats after 4 weeks of feeding of the diets. HMG-CoA
reductase is the rate-controlling enzyme of cholesterol
biosynthesis pathway. The mRNA level of HMG-CoA
reductase decreased by 25%, however without statistical
significance in the cholesterol-fed rats in comparison
with the control-diet rats. ACAT, a rate-controlling
enzyme of cholesterol esterification, and CYP7A1, a
rate-limiting enzyme of cholesterol hydroxylation, relate
hepatic cholesterol catabolism. mRNA levels of the two
enzymes were increased significantly in the cholesterol
group as compared with the controls. The result pre-
sented here showed the enhancement of cholesterol
hydroxylation and esterification and the suppression of
hepatic cholesterol synthesis. An interpretation of this
fact documented that the redundant cholesterol was
expelled from the liver.
Discussion
This study assessed the mechanism of the effect of diet-
ary cholesterol on lipid metabolism in rats. The results
demonstrated that the cholesterol administration signifi-
cantly increased the concentrations of the hepatic TC
and TG in rats (Table 4), which indicated that dietary
cholesterol obviously disturbed hepatic lipid metabolism.
Hepatic TG level is controlled mainly by TG synthesis,
beta-oxidation and secretion in form of lipoprotein [15].
Thomas et al. has reported that the hepatic TG accu-
mulation by high dietary cholesterol was involved in the
stimulation of fatty acid and TG synthesis in rats. But
there existed other studies indicating that the choles-
terol diet did not motivate the hepatic TG homeostasis
[16,17]. In the present study, the enzyme activity and
mRNA expression related to fatty acid and TG synthesis
were measured to investigate the effect of dietary cho-
lesterol on the distribution of TG and fatty acid to the
l i v e r .I nt h er e s u l t ,t h ea c t i v i t i e so fM E ,G 6 P D Ha n d
Table 5 Effects of cholesterol on enzyme activities
involved in hepatic lipid metabolism
1
Control Cholesterol
ME(nmol/min·mg protein ) 47.6 ± 4.0 27.7 ± 1.6 *
G6PDH(nmol/min·mg protein) 64.8 ± 7.5 18.7 ± 1.2*
FAS(nmol/min·mg protein ) 9.71 ± 1.64 5.19 ± 0.86*
PAP(nmol/min·mg protein ) 21.2 ± 1.0 18.2 ± 1.1**
CPT(nmol/min·mg protein ) 6.54 ± 0.40 5.00 ± 0.37**
1Data are presented as mean ± S.E.M. n = 7 rats per group.
ME, malic enzyme; G6PDH, glucose-6-phosphate dehydrogenase; FAS, fatty
acid synthase; PAP, phosphatidate phophatase; CPT, carnitine palmitoyl
transferase
*P < 0.05,**P < 0.01, compared to control group.
Figure 1 Effects of cholesterol on mRNA expression of hepatic fatty acid metabolism enzymes in rats. n = 7 rats per group. Data are
presented as mean ± S.E.M. FAS, fatty acid synthase; G6PDH, glucose-6-phosphate dehydrogenase; CPT, carnitine palmitoyl transferase.*P < 0.05,
**P < 0.01, compared to control group.
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fed rats were significantly lower than those in controls
(Table 5). And so it was with the activity of PAP, a rate-
limiting enzyme in TG biosynthesis. The down-regula-
tion of the genes was presented to coincide with the
reduction of the activity of the enzymes in the choles-
terol-fed rats (Figure 1A). Thus, we supposed that the
hepatic TG accumulation by dietary cholesterol was not
induced by the enhancement of the activity of the
enzymes involved in fatty acid and TG synthesis.
On the other hand, hepatic fatty acid beta-oxidation is
another factor to affect the hepatic fatty acid level.
CPT1 is the rate-limiting enzyme of the mitochondria
a-oxidation pathway. In the present study, hepatic
CPT1 activity (Table 5) and CPT1a and CPT2 mRNA
levels (Figure 1B) were inhibited drastically by the cho-
lesterol treatment. Those results demonstrated that the
cholesterol administration reduced fatty acid catabolism,
which may account for the enhancement of hepatic TG
level. Moreover, Fukada N et al. [18] have shown that
the suppression of fatty acid beta-oxidation may be
responsible for the conversion of fatty acid to TG and
CE. That was probably another reason to illustrate the
escalation of hepatic TG level.
Here we found that the serum TG level was signifi-
cantly lower in the cholesterol-fed rats than controls.
Whereas, other reports showed that hypercholesterole-
mia rats induced by high cholesterol diet had higher
serum TG level. Thomas et al.[1,2] observed that cho-
lesterol feeding increased the serum TG level in rats fed
with low fat diet (5%), but had no effect on the concen-
tration of serum TG in rats fed with high fat diet (20%).
Pang et al. [19] reported that cholesterol treatment
reduced the serum TG level in rats fed with high cho-
lesterol diet. Van. et al.[20] showed that the kind of
dietary fat was important for the serum TG level
effected by dietary cholesterol. Hence, there were indica-
tions that the effects of cholesterol on serum TG level
may be different depending on the distinct animal meta-
bolism states and diet compositions.
Besides, as we know, phospholipids are the main con-
tents of the surface of lipoprotein, and TG and CE
inside of it. This study showed that the cholesterol feed-
ing increased the serum LDL-c by 6-fold, and decreased
the serum TG level by 50%, but had no effect on PL
(Table 3). This fact may illustrate that the serum lipo-
protein was mainly consist of LDL abundant in CE in
the cholesterol-fed rats. Hence, we hypothesized that
the CE preferentially flew into the inside of LDL parti-
cle, as compared with the TG particle, amid the LDL
synthesis and secretion in the rats fed with cholesterol.
There are two pathways to reduce the hepatic choles-
terol level: cholesterol catabolism or incorporation into
the lipoprotein particles and release to the plasma in the
form of CE. Figure 2 presented that the gene expression of
HMG-CoA reductase, the key enzyme of cholesterol
synthesis, suppressed significantly in the cholesterol-fed
rats as compared with the control rats, which suggested
that the hepatic cholesterol biosynthesis was inhibited by
the high dietary cholesterol. As to the cholesterol degrada-
tion, the liver-specific enzyme CYP7A1, serves as a rate-
limiting enzyme in the classical pathway of bile acid con-
version into cholesterol, which is necessary for elimination
of cholesterol excess [21]. The up-regulation of CYP7A1
Figure 2 Effects of cholesterol on mRNA expression of hepatic cholesterol metabolism enzymes in rats. n = 7 rats per group. Data are
presented as mean ± S.E.M. ACAT, acyl-CoA: cholesterol acyltransferase; CYP7A1, cholesterol 7a-hydroxylase1.*P < 0.05,**P < 0.01, compared to
control group.
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cholesterol out of liver by dietary cholesterol. Hepatic cho-
lesterol integrates into the lipoprotein particles to form
CE, which plays the role of releasing cholesterol to plasma.
While ACAT acts as a rate-controlling enzyme of choles-
terol esterification, the enhancement of mRNA expression
of ACAT demonstrated the increasing cholesterol catabo-
lism by the cholesterol treatment (Figure 2). The result
also confirmed our presumption that the serum lipopro-
tein consist of LDL, which CE preferentially flew into by
the cholesterol administration.
Conclusions
Our finding suggested that the hepatic TG accumulation
caused by dietary cholesterol may attribute to the reduc-
tion of fatty acid beta-oxidation and the preference of
CE to afflux to LDL during the onset of biosynthesis
and secretion of LDL, not due to the enhancement of
the activity of the enzymes related to the fatty acid and
TG synthesis. But the detailed mechanism still needs
further investigation.
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